Patents by Inventor Yun Gao

Yun Gao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140030344
    Abstract: This invention relates to compositions, and related methods, of synthetic nanocarriers that target sites of action in cells, such as antigen presenting cells (APCs), and comprise immunomodulatory agents that dissociate from the synthetic nanocarriers in a pH sensitive manner. Also disclosed are compositions and methods relating to synthetic nanocarriers that encapsulate labile immunomodulatory agents that dissociate from the synthetic nanocarriers in a pH sensitive manner.
    Type: Application
    Filed: July 22, 2013
    Publication date: January 30, 2014
    Applicant: Selecta Biosciences, Inc.
    Inventors: Charles Zepp, Yun Gao, Mark J. Keegan, Sam Baldwin, Fen-ni Fu, Lloyd Johnston, Grayson B. Lipford
  • Publication number: 20140033278
    Abstract: In accordance with various embodiments, services gatekeeper systems and methods allow mapping and protecting communication services APIs with OAuth and group access to user information. Such a system can include a plurality of applications, executing on one or more application servers. The services gatekeeper is operable to define a group of members using a group URI, intercept requests for access to communication services APIs, obtain authorization from a group owner for access to a specified communication services API for each member of the group, and enable access to the specified communication services API of each member of the group in accordance with the scope authorized by the group owner.
    Type: Application
    Filed: July 25, 2012
    Publication date: January 30, 2014
    Applicant: ORACLE INTERNATIONAL CORPORATION
    Inventors: KIRANKUMAR NIMASHAKAVI, XU PENG WANG, YUN GAO, MIN FENG XU
  • Patent number: 8632849
    Abstract: An anti-counterfeit film comprising an amphichroic pattern is prepared by (1) mixing a polymerizable liquid crystal material of chiral structure and a photoinitiator, blade-coating the mixture on a base film and then drying; (2) partially exposing the resulting material produced in step (1) using a positioned UV lamp, then drying and exposing in an UV radiation to obtain a desired film. The film prepared by the method has an amphichroic pattern which typically presents a red and green picture when being vertically observed, the original red and green respectively changes into green and blue when being observed at a certain incline angel. The anti-counterfeit film is characterized by obvious color change, easy identification, practicability and convenience, thus facilitating promotion and application.
    Type: Grant
    Filed: June 9, 2009
    Date of Patent: January 21, 2014
    Assignee: Shanghai Techsun Anti-Counterfeiting Technology Holding Co., Ltd.
    Inventors: Liangheng Xu, Lanxin Dong, Yun Gao, Zhixi Zhang
  • Patent number: 8629151
    Abstract: This invention relates to compositions, and related compounds and methods, of conjugates of immunomodulatory agents and polymers or unit(s) thereof. The conjugates may be contained within synthetic nanocarriers, and the immunomodulatory agents may be released from the synthetic nanocarriers in a pH sensitive manner.
    Type: Grant
    Filed: May 26, 2010
    Date of Patent: January 14, 2014
    Assignee: Selecta Biosciences, Inc.
    Inventors: Charles Zepp, Grayson B. Lipford, Yun Gao, Lloyd Johnston, Fen-ni Fu, Mark J. Keegan, Sam Baldwin
  • Publication number: 20130203724
    Abstract: The present invention provides analogs of benzoquinone-containing ansamycins and uses thereof for treating and modulating disorders associated with hyperproliferation, such as cancer. The present invention provides analogs of benzoquinone-containing ansamycins where the benzoquinone is reduced to a hydroquinone and trapped by reaction with a suitable acid, preferably ones that increase the solubility and air stability of the resulting 17-ammonium hydroquinone ansamycin analog.
    Type: Application
    Filed: August 20, 2012
    Publication date: August 8, 2013
    Applicant: Infinity Discovery, Inc.
    Inventors: Julian Adams, Yun Gao, Asimina T. Georges Evangelinos, Louis Grenier, Roger H. Pak, James R. Porter, James L. Wright
  • Publication number: 20130068269
    Abstract: A folding canopy has a canopy top made of flexible sheet material; and a canopy frame. The canopy top is adapted to attach onto the canopy frame, and the canopy frame includes a number of members. A pair of left cross support bars have a first left cross support bar, and a second left cross support bar. The first left cross support bar is pivotally connected to the second left cross support bar. A pair of right cross support bars includes a first right cross support bar, and a second right cross support bar. The first right cross support bar is pivotally connected to the second right cross support bar.
    Type: Application
    Filed: September 20, 2011
    Publication date: March 21, 2013
    Inventor: Jian Yun Gao
  • Publication number: 20130039954
    Abstract: Disclosed are synthetic nanocarrier compositions that comprise B cell antigen for desired antibody production and an off-target response attenuating polymeric coating as well as related methods.
    Type: Application
    Filed: July 27, 2012
    Publication date: February 14, 2013
    Applicant: Selecta Biosciences, Inc.
    Inventors: Lynnelle Ann McNamee Pittet, David H. Altreuter, Yun Gao, Petr Ilyinskii, William Kuhlman
  • Publication number: 20130028857
    Abstract: This invention relates to compositions, and related methods, of synthetic nanocarriers that comprise polymers that comprise at least two immunomodulatory agent moieties.
    Type: Application
    Filed: July 27, 2012
    Publication date: January 31, 2013
    Applicant: Selecta Biosciences, Inc.
    Inventors: Yun Gao, David H. Altreuter
  • Patent number: 8362070
    Abstract: The invention relates to the new usage of puerarin in the field of pharmaceutical products, in other words, it relates to the application of puerarin in the preparation of drugs for P2X3 mediated pain/nervous system diseases. The experiment shows that puerarin can inhibit pain-related behavioral responses, subsequently immunohistochemical analysis, in situ hybridization, RT-PCR, protein blotting and other techniques were utilized to observe the inhibition of puerarin on mRNA and protein expression of P2X3 receptor in dorsal root ganglion of rats with neuropathic pain and in dorsal root ganglion and sensory nerve ending in the burn model of rats, it was found by using whole-cell patch clamp technique that puerarin can significantly reduce the electric current activated by P2X3 receptor agonist in the neuron of dorsal root ganglion of rats with neuropathic pain.
    Type: Grant
    Filed: June 29, 2010
    Date of Patent: January 29, 2013
    Assignee: Nanchang University
    Inventors: Shangdong Liang, Changshui Xu, Yun Gao, Guilin Li, Jiari Lin, Shuangmei Liu, Han Liu, Jun Zhang, Xin Li
  • Patent number: 8334082
    Abstract: A sensitive liquid crystalline polymeric material suitable for the reflective hologram recording and the preparing method thereof are disclosed. The material includes a base film, a buffer layer coated on one side of the base film, a sensitive polymeric layer coated on the other side of the buffer layer and a protective layer coated on the surface of the sensitive polymeric layer.
    Type: Grant
    Filed: July 29, 2008
    Date of Patent: December 18, 2012
    Assignee: Shanghai Techsun Anti-Counterfeiting Technology Holding Co., Ltd.
    Inventors: Liangheng Xu, Yun Gao, Renshun You, Kai Yang, Xuewen Xu
  • Patent number: 8252779
    Abstract: The present invention provides analogs of benzoquinone-containing ansamycins and uses thereof for treating and modulating disorders associated with hyperproliferation, such as cancer. The present invention provides analogs of benzoquinone-containing ansamycins where the benzoquinone is reduced to a hydroquinone and trapped by reaction with a suitable acid, preferably ones that increase the solubility and air stability of the resulting 17-ammonium hydroquinone ansamycin analog.
    Type: Grant
    Filed: July 27, 2011
    Date of Patent: August 28, 2012
    Assignee: Infinity Pharmaceuticals, Inc.
    Inventors: Julian Adams, Yun Gao, Asimina T. Georges Evangelinos, Louis Grenier, Roger H. Pak, James R. Porter, James L. Wright
  • Publication number: 20120171229
    Abstract: This invention relates to compositions, and related compounds and methods, of conjugates of synthetic nanocarriers, or components thereof, and biologically active agents, such as immunomodulatory agents, antigens, anticancer agents or antiviral agents. The biologically active agents are released from the synthetic nanocarriers in the presence of a reducing agent or by reaction with a thiol.
    Type: Application
    Filed: December 30, 2011
    Publication date: July 5, 2012
    Applicant: Selecta Biosciences, Inc.
    Inventors: Charles Zepp, Yun Gao
  • Publication number: 20120114677
    Abstract: Provided herein are compounds and related composition and methods that may be used to raise an antibody response to nicotinic compounds, in some embodiments.
    Type: Application
    Filed: November 4, 2011
    Publication date: May 10, 2012
    Applicant: Selecta Biosciences, Inc.
    Inventors: Charles Zepp, Yun Gao
  • Publication number: 20120064110
    Abstract: This invention relates to compositions and methods that can be used immunize a subject against influenza. Generally, the compositions and methods include peptides obtained or derived from human influenza A virus hemagglutinin.
    Type: Application
    Filed: August 19, 2011
    Publication date: March 15, 2012
    Applicant: Selecta Biosciences, Inc.
    Inventors: Petr Ilyinskii, Yun Gao, Fen-ni Fu, Grayson B. Lipford
  • Publication number: 20120058153
    Abstract: This invention relates to compositions and methods that can be used immunize a subject against influenza. Generally, the compositions and methods include polypeptides obtained or derived from human influenza A virus hemagglutinin.
    Type: Application
    Filed: August 19, 2011
    Publication date: March 8, 2012
    Applicant: Selecta Biosciences, Inc.
    Inventors: Petr Ilyinskii, Yun Gao, Grayson B. Lipford
  • Publication number: 20120058982
    Abstract: The present invention provides analogs of benzoquinone-containing ansamycins and uses thereof for treating and modulating disorders associated with hyperproliferation, such as cancer. The present invention provides analogs of benzoquinone-containing ansamycins where the benzoquinone is reduced to a hydroquinone and trapped by reaction with a suitable acid, preferably ones that increase the solubility and air stability of the resulting 17-ammonium hydroquinone ansamycin analog.
    Type: Application
    Filed: July 27, 2011
    Publication date: March 8, 2012
    Applicant: Infinity Pharmaceuticals, Inc.
    Inventors: Julian Adams, Yun Gao, Asimina T. Georges Evangelinos, Louis Grenier, Roger H. Pak, James R. Porter, James L. Wright
  • Publication number: 20120058154
    Abstract: This invention relates to compositions and methods that can be used immunize a subject against influenza. Generally, the compositions and methods include peptides obtained or derived from human influenza A virus M2 protein.
    Type: Application
    Filed: August 19, 2011
    Publication date: March 8, 2012
    Applicant: Selecta Biosciences, Inc.
    Inventors: Petr Ilyinskii, Yun Gao, Grayson B. Lipford
  • Publication number: 20110256351
    Abstract: An anti-counterfeit film comprising an amphichroic pattern is prepared by (1) mixing a polymerizable liquid crystal material of chiral structure and a photoinitiator, blade-coating the mixture on a base film and then drying; (2) partially exposing the resulting material produced in step (1) using a positioned UV lamp, then drying and exposing in an UV radiation to obtain a desired film. The film prepared by the method has an amphichroic pattern which typically presents a red and green picture when being vertically observed, the original red and green respectively changes into green and blue when being observed at a certain incline angel. The anti-counterfeit film is characterized by obvious color change, easy identification, practicability and convenience, thus facilitating promotion and application.
    Type: Application
    Filed: June 9, 2009
    Publication date: October 20, 2011
    Applicant: Shanghai Fudan Techsun New Technology Co., Ltd.
    Inventors: Liangheng Xu, Lanxin Dong, Yun Gao, Zhixi Zhang
  • Publication number: 20110216406
    Abstract: The present invention relates to a sheet enabling to form dynamic three-dimensional images and a device for preparing thereof. The sheet comprises a base layer (1), a transparent protective layer (2), a reflective layer (3), and pixel points (4) that can form images. The transparent protective layer (2) is disposed at one side of the base layer (1), the pixel points (4) are embedded in the transparent protective layer (2). The pixel points (4) consist of microlenses (401) tightly closed together. The reflective layer (3) is disposed downbently at a lower part of the microlenses (401), wherein picture-text is recorded in the reflective layer (3). There is an altitude difference H between horizontal positions of two adjacent pixel points (4). Microlenses (401) in any one of pixel point have the same curvature radius, and curvature radius of microlenses (401) in two adjacent pixel points (4) have a difference of 1 to 70 ?m.
    Type: Application
    Filed: August 11, 2009
    Publication date: September 8, 2011
    Applicant: Shanghai Fudan Techsun New Technology Co., Ltd.
    Inventors: Liangheng Xu, Aiming Ge, Yun Gao, Kai Yang
  • Patent number: 8003634
    Abstract: The present invention provides analogs of benzoquinone-containing ansamycins and uses thereof for treating and modulating disorders associated with hyperproliferation, such as cancer. The present invention provides analogs of benzoquinone-containing ansamycins where the benzoquinone is reduced to a hydroquinone and trapped by reaction with a suitable acid, preferably ones that increase the solubility and air stability of the resulting 17-ammonium hydroquinone ansamycin analog.
    Type: Grant
    Filed: October 6, 2010
    Date of Patent: August 23, 2011
    Assignee: Infinity Pharmaceuticals, Inc.
    Inventors: Julian Adams, Yun Gao, Asimina T. Georges Evangelinos, Louis Grenier, Roger H. Pak, James R. Porter, James L. Wright